BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
13 results:

  • 1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
    Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease.
    Ichinokawa H; Takamochi K; Fukui M; Hattori A; Matsunaga T; Suzuki K
    Thorac Cancer; 2022 Jul; 13(14):2024-2030. PubMed ID: 35637601
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications.
    Grześk G; Woźniak-Wiśniewska A; Błażejewski J; Górny B; Wołowiec Ł; Rogowicz D; Nowaczyk A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396592
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer adjuvant chemotherapy prediction model for non-small cell lung cancer.
    Alanni R; Hou J; Azzawi H; Xiang Y
    IET Syst Biol; 2019 Jun; 13(3):129-135. PubMed ID: 31170692
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Myeloid-derived suppressor cells inhibit T cell activation through nitrating lck in mouse cancers.
    Feng S; Cheng X; Zhang L; Lu X; Chaudhary S; Teng R; Frederickson C; Champion MM; Zhao R; Cheng L; Gong Y; Deng H; Lu X
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10094-10099. PubMed ID: 30232256
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
    Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
    Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
    Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A five-gene signature and clinical outcome in non-small-cell lung cancer.
    Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
    N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].
    Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D
    Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
    Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
    Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preclinical antitumor activity of water-soluble paclitaxel derivatives.
    Rose WC; Clark JL; Lee FY; Casazza AM
    Cancer Chemother Pharmacol; 1997; 39(6):486-92. PubMed ID: 9118459
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.